Posted Apr. 15, 2015 at 2:34 p.m.

Premium Lock Durham drug startup Innocrin raises $28M to advance cancer therapy

Published: 2015-04-15 14:34:20
Updated: 2015-04-15 14:34:20

VC funding  VC funding

Durham drug developer Innocrin Pharmaceuticals has closed on $28 million in Series D financing to test a new therapy for difficult prostate and breast cancers....

Read More
Read More

WRAL TechWire any time: Twitter, Facebook

Editor's Blog

Editor's Blog

The latest blog posts from our WRAL TechWire and WRAL editors. Read more articles…

Please Log In to add a comment.

Latest for Insiders